Efficacy of Omalizumab in Indolent Systemic Mastocytosis

Background. Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by the proliferation of clonal mast cells in skin and various internal organs. Omalizumab is an established, labelled therapy for allergic asthma and chronic urticaria, but its experience in the efficac...

Full description

Saved in:
Bibliographic Details
Main Authors: Calum Slapnicar, Martina Trinkaus, Lisa Hicks, Peter Vadas
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/3787586
Tags: Add Tag
No Tags, Be the first to tag this record!